Ditchcarbon
  • Contact
  1. Organizations
  2. DURECT Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 3 months ago

DURECT Corporation Sustainability Profile

Company website

DURECT Corporation, a leading biopharmaceutical company based in the United States, focuses on developing innovative therapeutics for chronic diseases and pain management. Founded in 1998, DURECT has made significant strides in the industry, particularly with its proprietary drug delivery technologies and formulations. Headquartered in Cupertino, California, the company operates primarily in the biopharmaceutical sector, specialising in long-acting injectable products and novel drug delivery systems. DURECT's core offerings, such as its DUR-928 and the SABER® technology platform, stand out for their potential to enhance patient outcomes through improved efficacy and reduced side effects. With a strong market position, DURECT has garnered attention for its commitment to advancing healthcare solutions, making it a notable player in the biopharmaceutical landscape.

DitchCarbon Score

How does DURECT Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

DURECT Corporation's score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.

27%

Let us know if this data was useful to you

DURECT Corporation's reported carbon emissions

DURECT Corporation, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that DURECT Corporation may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the industry increasingly prioritises sustainability, DURECT Corporation's future climate commitments will be crucial for aligning with broader environmental goals.

How Carbon Intensive is DURECT Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. DURECT Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is DURECT Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for DURECT Corporation is in US, which has a low grid carbon intensity relative to other regions.

DURECT Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

DURECT Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare DURECT Corporation's Emissions with Industry Peers

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Viatris

US
•
Pharmaceutical Preparation Manufacturing
Updated 28 days ago

Cumberland Pharmaceuticals Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Tris Pharma, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy